NDC 16729-366-16 - OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-366
- Requested NDC
- 16729-366-16
- Package NDCs from labels
- 16729-366-10, 16729-366-15, 16729-366-16, 16729-366-17, 16729-366-45, 16729-366-46
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACTOSE MONOHYDRATE - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE - A-S Medication Solutions | A-S Medication Solutions | 2023-07-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-366-10 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 16729-366-15 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 16729-366-16 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 7 | |
| 16729-366-17 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 7 | |
| 16729-366-45 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 16729-366-46 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 100 in 1 CARTON | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-366-10 | EA - Each | 16729-366 | 39fc2de8-f862-4a2d-a12c-bfab23d6c60e | 1 | 2020-09-14 |
| 16729-366-15 | EA - Each | 16729-366 | 3400d9ab-caf6-4425-9c27-24a6d36b5abb | 1 | 2020-09-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 1570f1ad-8372-477f-89c3-8c9ce01e27d1 | 2025-05-07 | Warnings, Adverse reactions | 0J48LPH2TH |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b7eeeb-09ae-ffe6-e063-6294a90aba90 | 2025-05-07 | Warnings | 15FIX9V2JP 1K09F3G675 |
| Vivier Sheer SPF 30 Mineral Tinted | TITANIUM DIOXIDE, ZINC OXIDE | Vivier Pharma, Inc. | e12e3bcb-4c3d-41be-8e2b-12a817c8b367 | 2025-05-05 | Warnings | 15FIX9V2JP |
| EltaMD UV AOX Elements | ZINC OXIDE, TITANIUM DIOXIDE SUNSCREEN | CP Skin Health Group, Inc | d01756c0-1f82-4e08-b956-8000ecaddfd1 | 2025-05-01 | Warnings | 15FIX9V2JP |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 82ad0fdf-5d47-4c2d-883b-f28b2d3fb6b0 | 2025-04-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | fea5a353-9b13-9b87-e053-6394a90a627d | 2025-04-25 | Warnings, Adverse reactions | 0J48LPH2TH |
| No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain | OCTINOXATE, TITANIUM DIOXIDE | BCM Cosmetique SAS | 2fbf7f9d-dba7-48f9-b10e-63225e8f1399 | 2025-04-25 | Warnings | 15FIX9V2JP |
| Algenist | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Solazyme, Inc. | 4ece1847-1c94-4bf7-b936-109556a460a7 | 2025-04-22 | Warnings | 15FIX9V2JP |
| Sulwhasoo Perfecting Cushion NO.17N1 Vanilla | OCTINOXATE, TITANIUM DIOXIDE, AND HOMOSALATE | Amorepacific Corporation | 3350f28e-22b4-904c-e063-6394a90a1c81 | 2025-04-21 | Warnings | 15FIX9V2JP |
| Cicapair Soothing Color Correcting Treatment Cica Complex Broad Spectrum SPF 30 | TITANIUM DIOXIDE AND ZINC OXIDE | Have & Be Co., Ltd. | 32c1aba6-5e29-aba9-e063-6394a90a8e56 | 2025-04-14 | Warnings | 15FIX9V2JP |
| REPAIRWEAR UPLIFTING FIRMING BROAD SPECTRUM SPF 15 DRY | OCTINOXATE, OCTISALATE, AND TITANIUM DIOXIDE | CLINIQUE LABORATORIES LLC | 07701e11-8a7e-44c5-b46e-5b48264eacad | 2025-04-14 | Warnings | 15FIX9V2JP |
| Smoothing Mineral Sunscreen Tinted | TITANIUM DIOXIDE, ZINC OXIDE | DANIEL BEHROOZAN MD A MEDICAL CORPORATION | 327246c2-9d7a-2d34-e063-6294a90a5fb7 | 2025-04-10 | 15FIX9V2JP | |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | NorthStar RxLLC | 364af4fe-cde8-466f-b56f-d93d532b56f5 | 2025-04-10 | Boxed warning, Warnings, Adverse reactions | 403855 403853 403854 0J48LPH2TH 6M97XTV3HD |
| Clarity Rx Physical Skin Defense SPF 50 | ZINC OXIDE AND TITANIUM DIOXIDE | Topiderm, Inc. | b5111012-97b9-4908-95a0-d09595f9c4d9 | 2025-04-10 | Warnings | 15FIX9V2JP |
| AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | Strides Pharma Science Limited | 9b76e441-e6a5-4036-8276-b7788ade5c44 | 2025-04-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Tinted Mineral Sunscreen SPF 50 | ZINC OXIDE AND TITANIUM DIOXIDE | Topiderm, Inc. | 13e5085f-df2b-46b2-b063-e58ce4379905 | 2025-04-09 | Warnings | 15FIX9V2JP |
| Zestoretic | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Almatica Pharma Inc. | 0d3a966f-f937-05a8-a90f-5aa52ebbd613 | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 0a49d951-dd1b-413b-99e5-d3119267c46c | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| City Skin Age Defense Broad Spectrum SPF 50 | TITANIUM DIOXIDE AND ZINC OXIDE | Murad, LLC | f8c572a2-b4bc-49e9-95df-359f05bd69b7 | 2025-03-28 | Warnings | 15FIX9V2JP |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Camber Pharmaceuticals, Inc. | 99865c67-5475-4e60-98d5-a8fa850fe9ba | 2025-03-26 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.